Microbix Biosystems Inc. (TSX:MBX)

Microbix Biosystems Statistics

Total Valuation

TSX:MBX has a market cap or net worth of CAD 30.54 million. The enterprise value is 25.20 million.

Market Cap	30.54M
Enterprise Value	25.20M

Important Dates

The next estimated earnings date is Thursday, February 12, 2026.

Earnings Date	Feb 12, 2026
Ex-Dividend Date	n/a

Share Statistics

TSX:MBX has 138.81 million shares outstanding. The number of shares has increased by 0.48% in one year.

Current Share Class	138.81M
Shares Outstanding	138.81M
Shares Change (YoY)	+0.48%
Shares Change (QoQ)	-3.12%
Owned by Insiders (%)	16.30%
Owned by Institutions (%)	0.43%
Float	116.18M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	1.64
PB Ratio	1.10
P/TBV Ratio	1.27
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-11.22
EV / Sales	1.36
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-28.71

Financial Position

The company has a current ratio of 8.48, with a Debt / Equity ratio of 0.24.

Current Ratio	8.48
Quick Ratio	4.94
Debt / Equity	0.24
Debt / EBITDA	105.91
Debt / FCF	-7.72
Interest Coverage	-1.66

Financial Efficiency

Return on equity (ROE) is -8.01% and return on invested capital (ROIC) is -2.85%.

Return on Equity (ROE)	-8.01%
Return on Assets (ROA)	-2.61%
Return on Invested Capital (ROIC)	-2.85%
Return on Capital Employed (ROCE)	-4.55%
Revenue Per Employee	185,854
Profits Per Employee	-22,458
Employee Count	70
Asset Turnover	0.49
Inventory Turnover	1.12

Taxes

Income Tax	-55,726
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -50.00% in the last 52 weeks. The beta is 0.43, so TSX:MBX's price volatility has been lower than the market average.

Beta (5Y)	0.43
52-Week Price Change	-50.00%
50-Day Moving Average	0.24
200-Day Moving Average	0.28
Relative Strength Index (RSI)	36.98
Average Volume (20 Days)	86,523

Short Selling Information

The latest short interest is 11,447, so 0.01% of the outstanding shares have been sold short.

Short Interest	11,447
Short Previous Month	4,761
Short % of Shares Out	0.01%
Short % of Float	0.01%
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, TSX:MBX had revenue of CAD 18.59 million and -2.25 million in losses. Loss per share was -0.02.

Revenue	18.59M
Gross Profit	9.85M
Operating Income	-1.58M
Pretax Income	-2.30M
Net Income	-2.25M
EBITDA	-139,620
EBIT	-1.58M
Loss Per Share	-0.02

Balance Sheet

The company has 12.11 million in cash and 6.77 million in debt, with a net cash position of 5.34 million or 0.04 per share.

Cash & Cash Equivalents	12.11M
Total Debt	6.77M
Net Cash	5.34M
Net Cash Per Share	0.04
Equity (Book Value)	27.79M
Book Value Per Share	0.20
Working Capital	20.80M

Cash Flow

In the last 12 months, operating cash flow was -80,287 and capital expenditures -797,297, giving a free cash flow of -877,584.

Operating Cash Flow	-80,287
Capital Expenditures	-797,297
Free Cash Flow	-877,584
FCF Per Share	-0.01

Margins

Gross margin is 53.02%, with operating and profit margins of -8.48% and -12.08%.

Gross Margin	53.02%
Operating Margin	-8.48%
Pretax Margin	-12.38%
Profit Margin	-12.08%
EBITDA Margin	-0.75%
EBIT Margin	-8.48%
FCF Margin	n/a

Dividends & Yields

TSX:MBX does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-0.48%
Shareholder Yield	-0.48%
Earnings Yield	-7.35%
FCF Yield	-2.87%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

TSX:MBX has an Altman Z-Score of 2.69 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.69
Piotroski F-Score	3